Eqis Capital Management Inc. acquired a new stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,137 shares of the company’s stock, valued at approximately $279,000.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. lifted its holdings in U.S. Physical Therapy by 3.6% in the 2nd quarter. BlackRock Inc. now owns 2,258,890 shares of the company’s stock worth $276,873,000 after purchasing an additional 79,478 shares in the last quarter. Nuveen Asset Management LLC purchased a new position in shares of U.S. Physical Therapy in the second quarter valued at $8,479,000. Scout Investments Inc. increased its position in U.S. Physical Therapy by 61.7% in the second quarter. Scout Investments Inc. now owns 105,386 shares of the company’s stock worth $12,917,000 after purchasing an additional 40,207 shares during the last quarter. Vanguard Group Inc. raised its stake in U.S. Physical Therapy by 4.5% during the second quarter. Vanguard Group Inc. now owns 881,582 shares of the company’s stock valued at $108,055,000 after purchasing an additional 37,926 shares in the last quarter. Finally, Copeland Capital Management LLC lifted its position in U.S. Physical Therapy by 20.3% during the second quarter. Copeland Capital Management LLC now owns 209,405 shares of the company’s stock valued at $25,667,000 after purchasing an additional 35,321 shares during the last quarter.
Shares of NYSE:USPH opened at $113.67 on Monday. The business’s 50 day moving average is $130.88 and its 200 day moving average is $126.61. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The stock has a market cap of $1.49 billion, a P/E ratio of 42.89, a price-to-earnings-growth ratio of 3.32 and a beta of 1.09. U.S. Physical Therapy, Inc. has a 52-week low of $98.69 and a 52-week high of $148.48.
U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.71 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.71. The company had revenue of $117.30 million for the quarter, compared to the consensus estimate of $121.28 million. U.S. Physical Therapy had a return on equity of 16.57% and a net margin of 6.36%. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.64 earnings per share. On average, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.86 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Monday, November 18th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.06%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio is currently 45.28%.
Several equities research analysts have weighed in on USPH shares. Zacks Investment Research raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Friday. ValuEngine raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research note on Friday, November 1st. Finally, Barrington Research raised U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 target price on the stock in a research note on Friday, November 8th. One analyst has rated the stock with a hold rating and three have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $127.20.
In other news, Director Harry S. Chapman bought 2,400 shares of U.S. Physical Therapy stock in a transaction on Monday, November 11th. The stock was acquired at an average price of $117.00 per share, with a total value of $280,800.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mark J. Brookner sold 1,000 shares of the firm’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $116.25, for a total transaction of $116,250.00. The disclosure for this sale can be found here. Insiders own 2.50% of the company’s stock.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading: Depreciation